368 Core collected for the violation of Covid-19

368 Core collected for the violation of Covid-19

New Delhi: The coronavirus has been raging for almost two years. Public life has been disrupted. And mask has played a measure role in the prevention of coronavirus. But Surprisingly in India 368 core of fine has been collected without wearing a mask.  In which 3 cities and 4 states of India were leading in the collection of the fine. In Gujarat, between June 27, 2020, and June 29, 2021, Rs 252 crore was collected from 34.72 lakh people for violating the law on wearing masks. Odisha Police have collected Rs 67 crore in fines for violations of Covid-19 regulations across the state in the past year. According to the data shared by the state police headquarters, altogether 7,979 cases were registered for rule violations in the last year. 

The Brihanmumbai Municipal Corporation collected Rs40 crore in fines. Bengaluru’s Municipal Corporation shows that over 3.70 lakh cases have been filed against citizens for not wearing masks and Rs 8.76 crore was collected by way of fines between May 2020 and February 7, 2021. The fine amount collected during the period was Rs 57.06 lakh. In total, 3.96 lakh violations have been registered with Rs 9.33 crore collected as a fine. In Uttar Pradesh, only on April 19, during the 35-hour curfew that in the wake of the rising Covid cases, police fined 31,325 people and collected a fine of Rs 64.16 lakh for not wearing a mask in public places. On March 22, a total of 1,260 people were fined in Madhya Pradesh’s Bhopal for not wearing masks, and around Rs 1.32 lakh was collected as a spot fine. 

Jharkhand Police has collected over Rs 35 lakh as fine from people for not wearing masks in public places. In this way, Gujarat was the highest state to collect the fine for the violation of Covid19 guidelines. That is more than what India annually pays to Afghanistan as development assistance. 

5 Essentials Foods To Boost Your Immunity Upcoming Monsoon

Top 5 Essentials Foods To Prepare Your Body For The Upcoming Monsoon

Monsoon diet: With the onset of monsoon, it is essential to boost your immunity to prevent infections. Here are some essential foods you can add to your diet for a healthy immune system.

Most of the cities have already started to experience the pre-monsoon showers and it's predicted that the monsoons should be here in full swing anytime! While this season is such a respite from the heat, the monsoon season comes with its own set of problems like viral fever, cough, cold, stomach infections, dengue, and malaria. Usually, with the onset of heavy reasons, your immune system tends to get compromised due to bacterial or viral infections. It goes without saying that a strong immune system and taking precautions is what's going to help you recover quickly and protect you against infections.

Whether it's prevention, recovery, healing - all that matters is your immune system as it's the first and last line of defense. Your immune system is made up of immune cells and each of these cells needs to have the right amount of energy through the food you eat, the water your drink, and the air you breathe. This is how one maintains a strong immune system.

There are foods that can help you enhance your immune system through this season, but these don't magically boost your immunity. They assist. Your immune system is a function of your overall lifestyle - right nutrition, quality and quantity of water, rest, recovery, sleep, emotional detox, and an active lifestyle to help circulate all the nutrients to all the trillions of cells in your body.

Simple, easily available, and inexpensive foods you can add to your diet this monsoon season

1. Hot Soups

Think monsoons, think hot soups. You can make pumpkin soup, tomato soup, moringa soup, green pea soup, mixed vegetable soup, or even something as simple as rasam. Pumpkin is a fantastic immunity booster due to a high concentration of beta carotene; vitamin C. Make sure you add garlic and ginger as they are highly anti-inflammatory and garlic literally works as an antibiotic and antifungal food. To this preparation, you can also add chilies, unless you have an acidity issue. Chilies are extremely rich in vitamin C too. In case you are a non-vegetarian, a simple chicken broth with spices and vegetables is fantastic immune-boosting food.

2. Oregano

Do you know why? Because of its extremely potent antifungal properties. Monsoons bring the risks of even acquiring fungal infections because the dampness and moisture provides a perfect and conducive environment for them to thrive.

You could simply brew oregano tea or season your salad and food with dried/fresh oregano leaves depending on what's available. Even 1-2 drops of edible oregano essential oil mixed in your water or soup works great. Oregano also benefits the respiratory system and helps loosen up the mucus and phlegm, especially when sipped warm.

3. Nuts and seeds

Whether it's hot or cold, you cannot go wrong with unsalted almonds, walnuts, peanuts, sunflower seeds, pumpkin seeds. Make sure you have some amount of these in a day. It could be a handful or less than that, but do not overdo them. Keep them balanced.

4. Cooked Crucifers

These are cabbage, cauliflower, broccoli, radish and are fantastic for controlling inflammation, fighting bacterial infections, and powerful immune boosters. Make sure they are well cleaned and cooked/steamed/blanched especially if you have a thyroid condition due to its goitrogenic effect. You can turn them into soups, stir-fries, soups, or vegetable preparations. 

5. Masala box/spice kit

Stock up on common kitchen spices because these are your go-tos during monsoons. Make use of common kitchen spices to boost immunity, such as turmeric, cumin, methi seeds, ginger, garlic, cloves, cinnamon, curry leaves, tulsi/basil leaves, and black pepper. You can make a concoction or a water infusion, or simply add these to your daily cooking.

You can also brew all of it together into a steaming cup of chai, without refined sugar. Instead, replace that with jaggery and you will notice how it only enhances the taste. So, in case your body craves that cup of chai this monsoon, you know you can go for it. Only make it the right way and add spices!

Bharat Biotech says it received no advance payment from Brazil govt for Covaxin

Bharat Biotech says it received no advance payment from Brazil govt for Covaxin

Reacting to the Brazil government nixing the Covaxin deal, Bharat Biotech on Wednesday 30 June 2021 said the company followed all step-by-step procedures and the vaccine price in the international market too was in public knowledge.

As the Brazil government suspends the deal to purchase 20 million doses of Bharat Biotech's Covaxin over allegations of graft in the the deal, the Hyderabad-based vaccine maker on Wednesday issued a statement and said as of June 29, the vaccine maker has not received any advance payment from the Brazil government. "In the case of procurement of Covaxin by Brazil, a step-by-step approach was followed towards contracts and regulatory approvals, during the 8-month-long process. EUA received was received on June 4. As of June 29, we haven't received any advance payments nor supplied vaccines to Brazil," the company said in a statement.

Brazil suspends Covaxin deal as Bolsonaro faces graft charges

"The pricing of Covaxin has been clearly established between $15-20 per dose for supplies to Governments outside India. The pricing for Brazil has also been indicated at $15 per dose," Bharat Biotech said.

The ₹2,400 crore has turned the heat up for the Jair Bolsonaro government as it was alleged that the government struck a deal with Bharat Biotech to acquire about 2 crore doses of Covaxin at a higher price, and at a time when the vaccine was not approved by the regulator of Brazil. Covaxin received emergency use authorisation in Brazil in the first week of June, though the negotiation process has been going on for the last seven-eight months.

Here's what happened

1.       Brazil Health Ministry official Luis Ricardo Miranda who acted as a whistleblower in this case raised suspicion about the deal as Pfizer was reportedly offering Brazil its Covid-19 vaccine at a lower price.

2.       Miranda looks after the imports of the health ministry and when he had to approve an import license, he refused to do so as the company mentioned in the invoice was not Bharat Biotech, the company with which the deal was signed, but some Singapore-based Madison Biotech.

3.       Luis Ricardo Miranda also told senators that he was under pressure to clear the deal.

4.       Bolsonaro defended the allegation saying that there was no corruption as the government did not pay any money and did not receive any vaccine.

5.     Covaxin was granted emergency use approval on June 5. Bharat Biotech also corroborated Bolsonaro's statement that no vaccine has been sent and no money has been received.

6.      Bharat Biotech has, however, said that Madison Biotech is its global sales and marketing arm.

7.     An investigation into the deal began in April.

8.     Brazil's newspapers reported that Bharat Biotech had initially quoted a price of $1.34 per dose, the government agreed to pay $15 per shot.

9.     Whistleblower Miranda and his brother who is a lawmaker met Bolsonaro “The President looked me in the eye and said, ‘This is serious’,” adding, “'If I interfere with this thing, you know what kind of shit it’s going to stir up. This must be so-and-so’s deal.’” the whistleblower has told the investigators.

10. Bharat Biotech said it followed all processes in Brazil as in other countries while the price of the vaccine in the international market was made public beforehand.

Explaining the process of how a country can procure vaccines from Bharat Biotech, the vaccine maker said that the company first received a letter of intent, following which it applues for emergency use authorisation in the country. Once the vaccine gets approval, the health ministry of that country releases a purchase order. Even if the order is placed before the approval, the procurement happens only after the approval.

Once the purchase order is released, the company raises a Pro Forma Invoice based on which the ministry makes the payment. Once the payment is received, the company proceeds to supply the vaccines. In this case, the company received no money from the health department of Brazil, Bharat Biotech said

Green Tea Might Help Tackle Covid

Green Tea Might Help Tackle Covid: Indian-Origin Researcher

Green Tea 

As India continues to be ravaged by the coronavirus pandemic, a team of researchers is investigating how green tea could give rise to a drug capable of tackling Covid-19.

The initial findings suggested that one of the compounds in green tea could combat the coronavirus behind Covid-19, said lead author Suresh Mohankumar, who researched during his time at JSS College of Pharmacy in Ooty before taking up his current role at Swansea University Medical School.

"Nature's oldest pharmacy has always been a treasure of potential novel drugs and we questioned if any of these compounds could assist us in battling the Covid-19 pandemic?" said Mohankumar.

"We screened and sorted a library of natural compounds already know to be active against other coronaviruses using an artificial intelligence-aided computer program," he added.

Mohankumar emphasized that the research was still in its early days and a long way from any kind of clinical application, in the study published in the journal RSC Advances.

"The compound that our model predicts to be most active is gallocatechin, which is present in green tea and could be readily available, accessible, and affordable," the researcher said.

There now needs to be further investigation to show if it can be proven clinically effective and safe for preventing or treating Covid-19.

"This is fascinating research and demonstrates that natural products remain an important source of lead compounds in the fight against infectious diseases," said Andrew Morris, Professor, Swansea University.

"I am also really pleased to see this international research collaboration continuing now that Mohankumar has joined the Pharmacy team," Morris added.

Green Tea Video Link 

Covid Unlock In Odisha

Covid Unlock In Odisha - 1 day Remaining for expiry of partial lockdown in the State 

1 day left before the expiry of the partial lockdown, the third phase of the pandemic curbs in Odisha this year, all eyes are now on the next move of the State government.

Even though in a majority of districts in the State, the graph of the virus cases has waned, the situation is still far from satisfactory in some districts, especially in the coastal belt.

Sources said the State Health Department is consulting various stakeholders before taking any decision on the next stage of pandemic restrictions while looking at Covid protocols, test positivity rate, and vaccination status.

Odisha government clamped down the lockdown restrictions for the first time this year after a massive resurgence in Corona cases. After enforcing the curbs from May 5 to 19 in the first phase and from May 19 to June 1, the government extended the lockdown till June 17. After a gradual dip and considerable improvement in various districts, the State authorities gave way to a series of relaxations in districts with low virus cases under a partial lockdown phase. But now intense public speculations continue to brew on whether similar partial lockdown restrictions will continue in Odisha with more relaxations or the period will see full phase unlocking activities based on the categorization of districts.

High placed sources indicate that the State government may go for more relaxations in the districts exhibiting less than 5% of TPR for an extended period of time. However, there is little or no likelihood of the opening of educational institutions, religious places which are places of mass public gathering because of virus outbreak scare.

It is also believed that decision on reopening businesses like salons, gyms, swimming pools, and restarting road public transport will be a massive challenge for the state administration.

In the meantime, the Chief of Directorate of Medical Education and Training (DMET), CBK Mohanty has said various aspects of the pandemic like positive count, active cases, vaccination numbers, hospitalization cases are being thoroughly analyzed on a district to district basis to prepare a comprehensive plan for the next stage of the unlocking activities.

Notably, Odisha has recorded 3319 virus cases in the last 24 hours. The trend of the daily cases furnished by the Health Department shows that the State continues to exhibit over 3000 plus new positives on a daily basis even a month and a week after registering its peak with over 12k cases on May 22.

While the average TPR of the State hovers around 5%, there are some districts like Puri, Khordha, Cuttack, Jagatsinghpur, Balasore, Jajpur, Bhadrak, and Mayurbhanj where the positivity rate continues its roller-coaster ride.

The Health Department has said that special strategies have been formulated after consultations with the authorities of these districts for further containing the virus cases.

Plastic Shields Don’t Stop Aerosol Transmission of Coronavirus

Plastic Shields Don’t Stop Aerosol Transmission of Coronavirus

Plastic Shields

• New researchTrusted Source finds that while wearing a surgical face mask can provide protection against airborne infection, face shields offer little or no protection.
• EvidenceTrusted Source suggests that SARS CoV-2, the virus that causes COVID-19, is transmitted when people expel virus-containing droplets when they sneeze or cough.
• StudiesTrusted Source has found that breathing and talking can expel droplets containing the virus. These particles remain airborne and may spread widely through a room.

Throughout the COVID-19 pandemic, people have used plastic visors and face shields for protection against potential infection in shops and other places where crowds gather.

However, a new researchTrusted Source presented at this year’s European Congress of Clinical Microbiology & Infectious Diseases finds that while wearing a surgical face mask can provide similar protection against airborne infection as wearing a respirator, face shields offer little or no protection.

The study, conducted by researchers at Philipps University Marburg in Marburg, Germany, compared 32 types of masks intended for use in hospitals, including cloth and surgical masks, respirators, and face shields.

Researchers found that surgical face masks had the lowest drop in pressure, providing the least resistance to breathing. Respirator-type masks had the highest pressure drop.

The cloth masks and the noncertified surgical masks performed the worst, only filtering out between 11.3 and 14.2 percent of particles. Surprisingly, a type II surgical face mask had similar “as worn” filtration results at 47 percent as KN95 respirators at 41 percent. The FFP2 respirators showed the best filtration, blocking 65 percent of particles.

Face shields were found to have no significant effect at all. the public should wear certified surgical face masks of good quality rather than cloth masks or face shields, which performed poorly in our study.

Deep Relaxation

 Deep Relaxation - Soulful Meditation flow of the river

Relax your self sit comfortably on a cushion or a chair or you can lay down wh

ere no one can distribute you for 5 minutes. Close your eyes and take a deep breath twice and concentrate on the breath moving in and out of your nostrils, or on the rise and fall of your belly. If you notice your mind wandering, bring it gently back to the breath no matter what feelings or thoughts you have, simply bring your focus back to the breath again and again. After meditating don not try to open your eyes immediately. Rub both of your hand places them on your forehead and face and slowly open both of your eyes.

Deep Relaxation - Soulful Meditation

The emotional cost of Covid-19 on infertile couples

The emotional cost of Covid-19 on infertile couples

Infertility is a condition of the reproductive system that is characterized by the inability to bear a child through natural ways. The emotional cost associated with infertility is best understood by individuals and couples who have been faced with the condition.

Our societies place great importance on conceiving and giving birth to a child. It is a societal norm that adults, especially married couples, start a family, and hence, there is mounting pressure when complications in the process arise. Infertility is a condition of the reproductive system that is characterized by the inability to bear a child through natural ways. The emotional cost associated with infertility is best understood by individuals and couples who have been faced with the condition.

The World Health Organisation has found that infertility afflicts one in every four couples in developing nations. In individuals and couples who are infertile, an outcome of their problems with reproductive health is an effect on their mental health. Both men and women have been found to have depression, anxiety, and feelings of loss of control, self-confidence, self-esteem, and isolation when they are unable to conceive.

A study conducted in 2016 that comprised 352 women and 274 men going in for treatments related to infertility has found that symptoms for depression are as widespread as 56 percent in women and 32 percent in men. In the same cohort, it was found that 76 percent of women and 61 percent of men had symptoms of anxiety.

It has also been found that women with fertility problems exhibit similar mental trauma as those diagnosed with diseases such as cancer and hypertension. Women who have miscarried in the past are more likely to be anxious about seeing through pregnancy to a successful live birth. Research and available data on the matter are more common about the consequences in women compared to their male counterparts.

The novel coronavirus pandemic that has hit the world has also had a grim impact on couples who were trying to conceive with the help of assisted reproductive technology (ART).

Globally and in India, IVF centers were closed when lockdowns were implemented so that the safety of both patients and staff can be ensured. The move that ensured patient and staff safety also left hundreds of couples stranded in the middle of treatment with no clarity when procedures will resume.

Now, with the second wave of Covid-19 and the increasing number of cases reported every day in the country and lockdowns implemented in different parts, infertile couples seeking treatment may find themselves at a difficult juncture yet again.

A study that was conducted in North America on the pandemic's effect on the mental health of women between ages 20 and 45 who were undergoing treatment found that 86 percent have observed a negative impact on their mental health and 52 percent have reported clinically significant symptoms for depression. This is true for people whose ART cycles were halted as clinics shut down around the world.

Not only this, research conducted by UK-based polling company Opinium on 533 women has discovered that three in five women who have just begun with their fertility treatment might consider taking intense healthcare. About half of those polled said they were willing to be overmedicated, with the knowledge of cons that include kidney failure, blood clots, and even pregnancy loss.

About seven in 10 women who took on such intensive medication said that they suffered from flashbacks, nightmares, and insomnia, all potential symptoms of post-traumatic stress disorder (PTSD). This has been triggered by the fear that Covid-19 is further shortening their reproductive window.

Although the aforementioned research was performed in countries other than India, the ground reality in our country could not be any different. In India, infertility is not a private medical condition but comes with a host of societal consequences. It is, thus, the only evidence that the inability to conceive naturally or otherwise will cause mental turmoil in couples. Many may even resort to unscientific means to have children.

Gradually, we are taking small steps towards accepting and living in the new normal. It is, therefore, established that over and above ensuring that couples are able to meet their reproductive health goals, specialists in ART must also look to ensure that the mental wellbeing of their patients is catered to.

It is imperative that the patients' mind is put to ease, not only in terms of their reproductive health but also their mental health with the aid of counseling and proper COVID-19-related standard operating safety procedures. Evidently, in addition to championing the cause of helping couples with their aspirations to have a family, fertility treatment providers also have to champion the cause of easing the mental burden of such individuals.

Second Made-In-India vaccine soon

Second Made-In-India vaccine soon: Centre finalizes advance to deal with Hyderabad-based firm for 30 crore doses

The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trials after showing promising results in Phase 1 and 2 clinical trials.

The Union Ministry of Health has finalized arrangements with Hyderabad-based vaccine manufacturer Biological-E to reserve 30 crores of COVID-19 vaccine doses. These vaccine doses will be manufactured and stockpiled by M/s Biological-E from August-December 2021. 

For this purpose, the Union Ministry of Health would be making an advance payment of Rs. 1500 crore to M/s Biological-E. 

The COVID-19 vaccine of Biological-E is currently undergoing Phase-3 clinical trials after showing promising results in Phase 1 and 2 clinical trials. The vaccine being developed by Biological-E is an RBD protein sub-unit vaccine and is likely to be available in the next few months.

The proposal of M/s Biological-E was examined and recommended for approval after due diligence by the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC). 

The arrangement with M/s Biological-E is part of the wider government's endeavor to encourage indigenous vaccine manufacturers by supporting research & Development (R&D) and financial support.  

Biological-E COVID Vaccine candidate has been supported by the government from the Preclinical stage to Phase-3 studies. Department of Biotechnology has not only provided financial assistance in terms of grant-in-aid of over Rs 100 cr but has also partnered with Biological-E to conduct all animal challenge and assay studies through its Research Institute Translational Health Science Technology Institute (THSTI), Faridabad.

This has been undertaken as part of the government's ‘Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission’ which was launched to reinforce and accelerate COVID-19 vaccine development efforts as part of the third stimulus package, Atmanirbhar 3.0.

The Mission aims to bring to the citizens a safe, efficacious, affordable, and accessible COVID-19 Vaccine. The Mission is supporting the development of 5-6 COVID-19 vaccine candidates. Some of these are now closer to licensure and introduction in public health systems. It has accelerated COVID-19 Vaccine development efforts and fostered a robust end-to-end vaccine development ecosystem in the country that will be available for other ongoing and future research and developmental activities for other vaccines.

2k Uttarakhand Cops Positive

2k Uttarakhand Cops Positive

According to data shared by authorities, more than 2,000 Uttarakhand Police personnel tested positive for Covid-19 in the second wave and 93 percent of them had received both doses of the vaccine before contracting the infection. The data, which was shared on Tuesday, says 2,382 policemen tested positive while they were on duty between April and May. Among them, 2,204 have already recovered while five deaths were reported. According to the data, two of the five policemen who died had comorbidities. The other three were not vaccinated. While some who died were deployed on duty at the Kumbh Mela in Haridwar, Bharne said there is no link between their deaths and the religious gathering.

Vitamin D May Not Prevent COVID-19 Risk

Vitamin D May Not Prevent COVID-19 Risk

A New Study Says Vitamin D Supplement May Not Prevent COVID-19 Risk

A study made by Bonnie Patchen, a Ph.D. student at Cornell University finding the link between vitamin D and COVID-19. In her findings of the new study are similar to what she and her colleagues found with their research, which was published May 4 in the journal BMJ Nutrition, Prevention & Health. Patchen said that in their research, she and her colleagues looked at how well the genetic variants predicted vitamin D levels across different populations. Their results were consistent for people of European ancestry, she said, even when taking into account other factors that can affect vitamin D levels such as body mass index (BMI) and older age. But the associations were less consistent in African ancestry individuals. Patchen said the level of variation is similar to a change that might be seen with taking a low-level supplement, around 400 to 600 International Units (IU) of vitamin D. But it doesn’t necessarily address the kind of acute changes in vitamin D levels that you might get with a high-dose treatment, Patchen explained. In another study, which was published on June 1 in the journal PLOS Medicine researchers at McGill University in Canada focused on genetic variants that are linked to increased vitamin D levels. People whose DNA contains one of these variants are more likely to naturally have higher levels of vitamin D, although diet and other environmental factors can still affect those levels. 

This type of analysis called Mendelian randomization study is like a genetic simulation of a randomized controlled trial, the “gold standard” for clinical research. Researchers found that people who have one of these variants - who are more likely to have higher vitamin D levels didn’t have a lower risk for coronavirus infection, hospitalization, or severe illness due to COVID-19.

Dr. Martin Kohlmeier, a professor of nutrition in the Gillings School of Global Public Health at the University of North Carolina, said “If you feed somebody a vitamin D supplement, it doesn’t matter how much you change the bound amount, it’s how much you change the free amount that matters for innate immunity.” The problem, he explained, is that the genetic variants used in Mendelian randomization studies of vitamin D are mainly related to the gene-binding protein for vitamin D.

Another study that was published February 17 in the journal JAMA, was carried out in Brazil. Where doctors gave patients COVID-19 patients a single oral dose of 200,000 IU of vitamin D, which is a very high dose, one that should only be taken under medical supervision or an inactive placebo. Researchers found that the large dose of vitamin D had no effect on patients’ length of stay in the hospital.

Dr. David Meltzer, a professor of medicine at The University of Chicago Medicine and his colleagues did their own analysis of the data from this study. They found that for people with low vitamin D levels, there was no effect of vitamin D levels on COVID-19 outcome. But it was a different story for people who entered the hospital with higher levels. The people with high vitamin D who were given additional vitamin D actually did better. 

Like Kohlmeier, Meltzer thinks it’s important to test the effect of vitamin D supplementation on COVID-19 risk, rather than just look at the levels in the blood. The vitamin D intake that you have on a daily basis or the amount you produce through sun exposure probably matters to some degree, he said, independently of your blood levels.

The results from these studies, which may not be available until later this year may provide a better idea of whether vitamin D can prevent respiratorily infections such as COVID-19.

Good News for Drinkers

 Good News for Drinkers

Corona's second wave is slowly receding in many parts of the country. The capital, Delhi, is also witnessing a decline in the number of cases of corona positive cases. Meanwhile, Chief Minister Arvind Kejriwal has given permission for Alcohol Home Delivery in Delhi. However, the Aam Aadmi Party (AAP) government has allowed domestic and foreign Liquor to deliver home. Delhiites can order wine through mobile apps and online web portals. The government has already imposed a number of sanctions on Corona. There were also restrictions on the sale of wine. But now the government has decided to crack down on alcohol sales. Apart from Delhi, the Chhattisgarh government has also allowed Alcohol home delivery. The decision was made in view of the crowds in front of the liquor store during the coronation.

Covid-19 Update - India

 Today Covid-19 Updates - India

The new Covid19 cases in India according to the Ministry of Health and Family Welfare of India data updated on Friday 28.05.2021. A total of 186,364 new coronavirus infections were reported in a day, the lowest in around 44 days, while the number of death in India is 

3,660. 2,48,93,410 total recover across the country so far and 259,459 patients recovered during the last 24 hours. Recovery Rate increases to 90.34%. 

Whereas in Odisha 

New Positive Cases in the last 24hours - 7216 and 11551 Covid patients have recovered and are being discharged on 27.05.2021 and 33 Covid positive patients lost their lives under treatment in hospitals as said by H&FW dept. Odisha.   

Covid19-India

India reports 1.96lkh Covid19 cases with 3,511 deaths in past 24hrs

According to the Union Health Ministry, the country recorded 1,96,427 lakh new coronavirus with 3,511 deaths in last 24 hours. With this, the total cases of Covid-19 recorded so far are 2,69,48,874 while the Death toll stands at 3,07,231.

Total cases: 2,69,48,874

Total discharges: 2,40,54,861

Death toll: 3,07,231  

Active cases: 25,86,782  

Total vaccination: 19,85,38,999

ICMR reported that total 33,25,94,176 samples for Covid-19 were tested up to 24th May including 20,58,112 samples tested in the past 24 hours. The top five states that registered maximum cases are Tamil Nadu with 34,867 cases, followed by Karnataka with 25,311 cases, Maharashtra with 22,122 cases, West Bengal with 17,883 cases and Kerala with 17,821 cases, said the Health Ministry. 60.07 percent of the new cases were reported from these five states.

The Union Health Ministry meanwhile said that cumulative number of COVID19 vaccine doses administered in the country exceeded 19.84 corers (19,84,43,550) on Monday.

 

Covid19-Odisha

Odisha Covid19 reports for 24th May

According to the H & FW Department and I & PR Department of Odisha on Tuesday 24May2021 Odisha new Covid19 cases 10939 with 33 deaths and new recoveries 11614.

District Wise Cases:

1.       Angul: 819

2.       Balasore: 361

3.       Bargarh: 323

4.       Bhadrak: 142

5.       Balangir: 195

6.       Boudh: 385

7.       Cuttack: 922

8.       Deogarh: 100

9.       Dhenkanal: 763

10.   Gajapati: 43

11.   Ganjam: 254

12.   Jagatsinghpur: 291

13.   Jajpur: 541

14.   Jharsuguda: 191

15.   Kalahandi: 244

16.   Kandhamal: 77

17.   Kendrapada: 323

18.   Keonjhar: 176

19.   Khurda: 1298

20.   Koraput: 242

21.   Malkangiri: 103

22.   Mayurbhanj: 604

23.   Nawarangpur: 362

24.   Nayagarh: 225

25.   Nuapada: 64

26.   Puri: 456

27.   Rayagada: 156

28.   Sambalpur: 319

29.   Sonepur: 231

30.   Sundargarh: 512

31.   State Pool: 217

Cumulative tested: 11437337

Positive:                    714380

Recovered:               601224

Active cases:            110554